HonorHealth Research Institute

City:

Amount: $100000

Award Date: 2026

Duration: 18 months

Program Area: Bioscience

Translational Seed Grant: Glioblastoma Multiforme (GBM) remains a formidable clinical challenge with limited efficacy of current immunotherapies. The team has developed a therapy to rapidly identify tumor-specific targets unique to each patient, triggering more effective tumor cell killing.